• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

顺二氯二氨铂(II)在雄性和雌性大鼠的肾脏、性腺及肿瘤组织中与DNA形成加合物的情况。

cis-Diamminedichloroplatinum (II)-DNA adduct formation in renal, gonadal, and tumor tissues of male and female rats.

作者信息

Reed E, Litterst C L, Thill C C, Yuspa S H, Poirier M C

出版信息

Cancer Res. 1987 Feb 1;47(3):718-22.

PMID:3802077
Abstract

cis-Diamminedichloroplatinum(II) (cisplatin), a potent anticancer agent, is thought to exert its cytotoxic effects through DNA damage. Using a polyclonal rabbit antisera which recognizes intrastrand bidentate deoxy(ApG)- and deoxy(GpG)-N7-diammineplatinum adducts, an enzyme-linked immunosorbent assay has been developed to quantitate this adduct in cisplatin-exposed DNA. Cisplatin-DNA adducts were measured in renal, gonadal, and tumor (sarcoma) tissues of Sprague-Dawley rats following i.v. or i.p. administration of cisplatin. When drug was administered i.v. to animals fed ad libitum adduct levels were highest in kidneys, 50% lower in s.c. sarcoma, and substantially lower in gonads. Under these experimental conditions, a large interindividual variability in adduct formation was observed in renal and tumor tissues, and adduct levels in some samples were too low to measure. Higher values among individuals were obtained using tissues of animals fasted overnight and treated i.p. Adduct levels following i.p. injections of drug were higher in kidneys and gonads of male rats than in kidneys and gonads of female rats. Analysis of tissue platinum content demonstrated higher platinum levels in kidneys of male rats than in kidneys of female rats, but the magnitude of this gender difference in total tissue platinum was not as great as that observed for adduct formation. When the influence of castration on adduct formation was investigated, adduct levels in kidneys of castrated females were higher than those in sham-operated females, but adduct levels in kidneys of the castrated male animals were not substantively different from those seen in sham-operated male controls. We conclude that the route of drug administration, diet, and hormonal status of the animal are factors that may influence cisplatin-DNA adduct formation in the rat.

摘要

顺二氯二氨合铂(II)(顺铂)是一种强效抗癌剂,被认为通过DNA损伤发挥其细胞毒性作用。利用一种能识别链内双齿脱氧(ApG)-和脱氧(GpG)-N7-二氨铂加合物的多克隆兔抗血清,开发了一种酶联免疫吸附测定法来定量顺铂处理的DNA中的这种加合物。在静脉内或腹腔内给予顺铂后,测定了Sprague-Dawley大鼠的肾、性腺和肿瘤(肉瘤)组织中的顺铂-DNA加合物。当对自由采食的动物静脉内给药时,加合物水平在肾脏中最高,在皮下肉瘤中低50%,在性腺中则低得多。在这些实验条件下,在肾和肿瘤组织中观察到加合物形成存在很大的个体间差异,并且一些样品中的加合物水平过低无法测量。使用过夜禁食并经腹腔内处理的动物的组织,个体间获得了更高的值。腹腔内注射药物后,雄性大鼠肾和性腺中的加合物水平高于雌性大鼠肾和性腺中的加合物水平。组织铂含量分析表明,雄性大鼠肾脏中的铂水平高于雌性大鼠肾脏中的铂水平,但这种性别差异在总组织铂中的幅度不如加合物形成中观察到的那么大。当研究去势对加合物形成的影响时,去势雌性大鼠肾脏中的加合物水平高于假手术雌性大鼠,但去势雄性动物肾脏中的加合物水平与假手术雄性对照中观察到的没有实质性差异。我们得出结论,药物给药途径、饮食和动物的激素状态是可能影响大鼠顺铂-DNA加合物形成的因素。

相似文献

1
cis-Diamminedichloroplatinum (II)-DNA adduct formation in renal, gonadal, and tumor tissues of male and female rats.顺二氯二氨铂(II)在雄性和雌性大鼠的肾脏、性腺及肿瘤组织中与DNA形成加合物的情况。
Cancer Res. 1987 Feb 1;47(3):718-22.
2
Persistence of platinum-ammine-DNA adducts in gonads and kidneys of rats and multiple tissues from cancer patients.铂氨-DNA加合物在大鼠性腺和肾脏以及癌症患者多种组织中的持久性。
Cancer Res. 1992 Jan 1;52(1):149-53.
3
Platinum concentrations and DNA adduct levels in tumors and organs of cisplatin-treated LOU/M rats inoculated with cisplatin-sensitive or -resistant immunoglobulin M immunocytoma.接种顺铂敏感或耐药免疫球蛋白M免疫细胞瘤的顺铂处理的LOU/M大鼠肿瘤及器官中的铂浓度和DNA加合物水平。
Cancer Res. 1989 Jun 1;49(11):2862-7.
4
Kinetics of the formation and removal of cisplatin-DNA adducts in blood cells and tumor tissue of cancer patients receiving chemotherapy: comparison with in vitro adduct formation.接受化疗的癌症患者血细胞和肿瘤组织中顺铂-DNA加合物形成与去除的动力学:与体外加合物形成的比较。
Cancer Res. 1990 Dec 15;50(24):7887-94.
5
Relationship between patient response in ovarian and breast cancer and platinum drug-DNA adduct formation.卵巢癌和乳腺癌患者反应与铂类药物-DNA加合物形成之间的关系。
Cancer Epidemiol Biomarkers Prev. 1993 May-Jun;2(3):229-34.
6
Differential sensitivity to the induction of apoptosis by cisplatin in proliferating and quiescent immature rat thymocytes is independent of the levels of drug accumulation and DNA adduct formation.增殖期和静止期未成熟大鼠胸腺细胞对顺铂诱导凋亡的敏感性差异与药物积累水平和DNA加合物形成无关。
Cancer Res. 1994 Mar 15;54(6):1596-603.
7
The formation and persistence of carboplatin-DNA adducts in rats.卡铂 - DNA加合物在大鼠体内的形成与持久性。
Cancer Chemother Pharmacol. 1996;38(3):273-80. doi: 10.1007/s002800050482.
8
Inductively coupled plasma mass spectroscopy quantitation of platinum-DNA adducts in peripheral blood leukocytes of patients receiving cisplatin- or carboplatin-based chemotherapy.电感耦合等离子体质谱法定量分析接受顺铂或卡铂化疗患者外周血白细胞中的铂-DNA加合物。
Clin Cancer Res. 1996 Nov;2(11):1829-35.
9
DNA adducts of cisplatin and carboplatin in tissues of cancer patients.癌症患者组织中顺铂和卡铂的DNA加合物
IARC Sci Publ. 1988(89):313-20.
10
Human testis-determining factor SRY binds to the major DNA adduct of cisplatin and a putative target sequence with comparable affinities.人类睾丸决定因子SRY以相当的亲和力与顺铂的主要DNA加合物及一个假定的靶序列结合。
Biochemistry. 1998 Jan 6;37(1):352-62. doi: 10.1021/bi971675q.

引用本文的文献

1
The multiple facets of drug resistance: one history, different approaches.耐药性的多方面:一段历史,不同方法。
J Exp Clin Cancer Res. 2014 Apr 28;33(1):37. doi: 10.1186/1756-9966-33-37.
2
An Engineered Arginase FC Protein Inhibits Tumor Growth In Vitro and In Vivo.工程化精氨酸酶 FC 蛋白在体外和体内抑制肿瘤生长。
Evid Based Complement Alternat Med. 2013;2013:423129. doi: 10.1155/2013/423129. Epub 2013 May 8.
3
Repair capacity for platinum-DNA adducts determines the severity of cisplatin-induced peripheral neuropathy.
铂-DNA加合物的修复能力决定了顺铂诱导的周围神经病变的严重程度。
J Neurosci. 2007 Aug 29;27(35):9451-7. doi: 10.1523/JNEUROSCI.0523-07.2007.
4
Comparative adverse effect profiles of platinum drugs.铂类药物的比较不良反应概况。
Drug Saf. 1995 Oct;13(4):228-44. doi: 10.2165/00002018-199513040-00003.
5
Factors affecting human autopsy kidney-cortex and kidney-medulla platinum concentrations after cisplatin administration.顺铂给药后影响人体尸检肾皮质和肾髓质铂浓度的因素。
Cancer Chemother Pharmacol. 1994;34(1):14-22. doi: 10.1007/BF00686106.
6
Current sample handling methods for measurement of platinum-DNA adducts in leucocytes in man lead to discrepant results in DNA adduct levels and DNA repair.目前用于测量人体白细胞中铂-DNA加合物的样本处理方法,导致DNA加合物水平和DNA修复结果存在差异。
Br J Cancer. 1995 Mar;71(3):512-7. doi: 10.1038/bjc.1995.102.
7
Pharmacokinetics and tissue distribution of cisplatin in nude mice: platinum levels and cisplatin-DNA adducts.顺铂在裸鼠体内的药代动力学和组织分布:铂含量和顺铂-DNA加合物
Cancer Chemother Pharmacol. 1995;37(1-2):23-31. doi: 10.1007/BF00685625.
8
Platinum-DNA adducts in leukocyte DNA correlate with disease response in ovarian cancer patients receiving platinum-based chemotherapy.接受铂类化疗的卵巢癌患者白细胞DNA中的铂-DNA加合物与疾病反应相关。
Proc Natl Acad Sci U S A. 1987 Jul;84(14):5024-8. doi: 10.1073/pnas.84.14.5024.
9
Quantitative subcellular distribution of platinum in rat tissues following i.v. bolus and i.v. infusion of cisplatin.静脉推注和顺铂静脉输注后大鼠组织中铂的定量亚细胞分布。
Cancer Chemother Pharmacol. 1990;26(3):188-92. doi: 10.1007/BF02897197.